LY3962681 clinical trials

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

This study is testing a new medicine, LY3962681, for Parkinson's disease. It aims to check if the medicine is safe, well-tolerated, and how it works in both healthy people and those with Parkinson's. The medicine is given into the fluid around the spine.